Objective: The purpose of this study was to describe a blinded intra-aortic balloon occlusion (IABO) procedure in pelvic fractures (PF) for patients with critically uncontrollable hemorrhagic shock (CUHS). Methods: Of 2,064 patients treated for PF, 13 underwent IABO during initial resuscitation to control massive pelvic bleeding leading to CUHS. Our IABO procedure consists of internal aortic occlusion without fluoroscopy, using a latex balloon inflated in the infrarenal aorta. Retrospectively collected data included demographics, fracture classification, additional injuries, blood transfusions, surgical interventions, angiographic procedure, physiologic parameters, and survival. Results: All balloons were successfully placed, and a significant increase in systolic blood pressure (70 mm Hg, p ϭ 0.001) was observed immediately after IABO. Twelve of 13 patients became transferrable. Angiography performed after IABO was positive for arterial injury in 92% of patients, and 9 patients benefitted from arterial embolization. Survival rate was 46% (6 of 13) and was inversely related to the length of inflation (p ϭ 0.026) and the mean Injury Severity Score (p ϭ 0.011). Conclusion: This IABO procedure can be life saving in the management of patients with CUHS from PF, permitting transport to angiography. However, the decision for such treatment must be as quickly as possible after trauma to reduce the time of occlusion.
P elvic fractures (PF) are associated with a global mortality rate ranging from 3% to 30%. [1] [2] [3] When complicated by hemodynamic instability (10 -20% of PF), mortality rates rise to ϳ40%. 4 Despite improvements in hemodynamic resuscitation, some patients do not respond to resuscitation, and the mortality rates in this population may be as high as 64% when transfusion of Ͼ20 units of blood are required. 5 The mortality may rise to 78% when systolic blood pressure (SBP) is Ͻ90 mm Hg, 6 to 90% in cases of cardiac arrest out of hospital, 7 and up to 100% when the Injury Severity Score (ISS) is Ͼ57. 8 Prehospital admission care (resuscitation and pelvic binding) and external fixation have improved management of bleeding from PF, especially in the case of venous bleeding. The cause of uncontrollable hemorrhagic shock in PF is primarily because of arterial hemorrhage, 9, 10 and transcatheter arterial embolization (TAE) still remains the most appropriate treatment for these arterial hemorrhages. 4, [11] [12] [13] Unfortunately, the hemorrhagic shock may preclude transport of the patient to the angiographic suite.
Intra-aortic balloon occlusion (IABO) has already been described for the treatment of hemorrhagic shock in the case of ruptured abdominal aortic aneurysm, 14 in abdominal trauma, 15 in gastrointestinal bleeding, 16 and in postpartum hemorrhage. 17 A balloon occlusion of an iliac artery has also been proposed in PF with uncontrollable hemorrhagic shock. 18 In our trauma center, we have developed a technique of blind insertion of a balloon catheter for occlusion of the infrarenal aorta in an effort to eliminate the need for fluoroscopic guidance in patients with PF. We report our experience of IABO in critically uncontrollable hemorrhagic shock (CUHS) after PF to allow time for effective resuscitation, transport, and embolization and, thus, decrease the mortality rate in this population.
MATERIALS AND METHODS
From 1998 to 2007, 2,064 patients were admitted in our Level I trauma for PF and 74 benefited from embolization. During the same period, 13 patients with PF and CUHS benefited from IABO.
During the study period, the management algorithm for pelvic trauma was as follows: patients suspected of having a PF complicated by hemorrhagic shock were managed at the site of the crash by a medical team and were in some cases equipped with medical antishock trousers; resuscitation began with perfusion of crystalloids and colloids. On arrival at the hospital, patients were admitted to the shock room of the emergency department, and a team composed of the intensive care unit (ICU) physician, the trauma surgeon, and the interventional radiologist were waiting for them. Immediately after admission, thoracic and pelvic X-rays and a focused abdominal sonography for trauma (FAST) examination were performed. The diagnosis and classification of PF was made on pelvic X-ray, according to the classification of the Orthopaedic Trauma Association Committee for Coding and Classification. 19 If another cause of hemorrhage was detected (such as external, thoracic, or abdominal bleeding), this was first treated. If the hemorrhage was judged to be related to the PF, the decision to use external fixation was based on type of PF and the availability of an orthopedic surgeon.
Patients with persistent hemorrhage were candidates for embolization. In our center, the angiography room is located at a different floor level of the hospital, and thus the patients would have had to tolerate transfer to the suite before they could be embolized.
The hemodynamic status was qualified as CUHS when, even after perfusion of 3 L of intravenous crystalloid or 2 L of colloids and at least 1 unit of red blood cells (RBC), and use of epinephrine or norepinephrine, the SBP remained Ͻ60 mm Hg, a cardiac arrest occurred during resuscitation, and/or the SBP could not be restored Ͼ90 mm Hg after 1 hour of resuscitation. In this setting of imminent death, patient transport to the angiographic suite is precluded. Thus, the decision to perform IABO is made.
The IABO procedure was always performed by a senior experienced interventional radiologist. The most accessible common femoral artery was chosen, and a 10-Fr sheath was inserted. A 20-mm Berenstein latex balloon (Boston scientific, Natick, MA) was introduced in the sheath up to 50 cm, to be located in the aorta. Then, the balloon was slowly inflated with saline solution, while continuous gentle back and forth movements were performed until friction with the aortic wall was felt. The balloon was then withdrawn until wedged in the aortic bifurcation. The balloon was advanced again 5 cm upward to be located in the infrarenal aorta and inflated to obtain occlusion of the aorta. Absent femoral pulses were verified bilaterally to ensure the efficacy of the aortic occlusion.
In our series, IABO procedure was performed in the shock room after admission following the algorithm previously described (n ϭ 10), in the operating room after a first intent splenectomy (n ϭ 1), and in secondary hospitals without angiographic facilities (n ϭ 2). For these two cases, a medical team including an interventional radiologist was transported to the site by ambulance (n ϭ 1) or helicopter (n ϭ 1).
The TAE was performed through the same introducer sheath after the aortic balloon being withdrawn or still inflated (a 4-Fr angiographic catheter being inserted coaxially to the balloon catheter). Statistical analysis was performed using Statview 5.0 (SAS Institute, Cary, NC). Continuous data are presented as mean Ϯ standard deviation. The level of significance was set at p Ͻ 0.05.
RESULTS

Population
Thirteen patients benefitted from IABO and were included in the study. The population characteristics are resumed in Table 1 . The mean age was 42 years Ϯ 14 years.
The mechanism of injury was a motor vehicle or pedestrian crash (n ϭ 5) and vertical fall (n ϭ 8). The fracture mechanism was an anteroposterior compression in 1 case, a lateral compression in 1 case, and a vertical shear in 11 cases. PF were classified according to the Orthopaedic Trauma Association Committee for Coding and Classification 19 as type B in 2 cases and type C in 11 cases. In addition to their PF, 11 patients suffered from associated injuries: 61% (n ϭ 8) of patients had associated head injuries, 77% (n ϭ 10) thoracic injuries, 54% (n ϭ 7) abdominal injuries, and 69% (n ϭ 9) extremity injuries. The mean ISS 20 was 48 Ϯ 16, including six patients with an ISS Ͼ57. The mean Revised Trauma Score 21 was 4.59 Ϯ 2.35. The predicted mortality based on Trauma ISS 22 was 61% Ϯ 27%. Table 2 reports specific data for each patient.
Patient Management
On arrival, four patients were equipped with a medical antishock trousers. For these patients, the pelvic segment of the trousers was carefully removed for IABO. The indication for IABO was at least one of the criteria of CUHS: (1) one or more cardiac arrests after an hemorrhagic shock (n ϭ 2); (2) SBP Ͻ60 mm Hg (n ϭ 10); and (3) an UHS lasting Ͼ1 hour despite resuscitation (n ϭ 8).
All patients had chest and pelvic X-rays, and 12 patients had FAST in the shock room at their arrival. Two patients, one in our institution and another in a secondary hospital, had a computed tomography (CT) scan before IABO, because they were initially hemodynamically stable. Two patients had a CT scan after IABO (patients 1 and 5), and this resulted in a mean increase in the delay before embolization of 56 minutes (these 2 patients died). Because of concern that CT imaging might delay therapy, it was decided to proceed directly to angiography with all subsequent patients regardless of hemodynamic status.
Physiologic Parameters
Despite resuscitation, the mean SBP was 41 mm Hg Ϯ 26 mm Hg. One patient was in cardiac arrest during the IABO procedure (patient 11), and another one presented three cardiac arrests before IABO (patient 9, Fig. 1 ). Because of their hemodynamic status, none of the patients (n ϭ 13) were transportable before IABO.
After IABO, the mean SBP increased to 111 mm Hg Ϯ 47 mm Hg. The increase in blood pressure was statistically significant when compared with blood pressure before IABO (p ϭ 0.001; Table 3 ). Twelve patients (92%) were transportable to the angiographic room after Although the heart rate decreased slightly from 117 bpm Ϯ 40 bpm to 112 bpm Ϯ 21 bpm, the difference was not statistically significant (p ϭ 0.5836). The mean total volume for fluid resuscitation (crystalloids/colloids) was 5.6 L Ϯ 1.6 L, and patients received 19 units Ϯ 12 units of RBC and 5.8 units Ϯ 4.8 units of fresh-frozen plasma. The mean pH was 7.09 Ϯ 0.05 and the median was 7.06, but the pH value could not be retrieved for five patients.
Technical Results
In all cases, the balloon was successfully placed in intravascular position. One balloon ruptured and was immediately replaced. In 12 patients, the balloon position was verified by angiography and was located in the aorta (n ϭ 10) or in the origin of an iliac artery (n ϭ 2). Nevertheless, in the latter cases, by occluding the wounded iliac axis, the balloon was clinically effective and was, thus, considered as a success.
The IABO was placed 197 minutes Ϯ 135 minutes (range, 75-580 minutes) after trauma and 110 minutes Ϯ 82 minutes (range, 15-300 minutes) after admission to the ICU. The longest delay was for a patient who was initially stable at admission and suddenly worsened (patient 8). The mean occlusion time was 70 minutes Ϯ 39 minutes, with a median of 60 minutes.
For 12 patients, the balloon was carefully deflated during the TAE procedure, either before angiography (n ϭ Figure 1 . A 48-year-old man (patient 9) was admitted to a secondary hospital without angiography suite, after being crushed by a truck. He presented a major PF type C3 but no other hemorrhagic lesion at focused abdominal sonography for trauma-US and chest computed radiography. He rapidly suffered shock. An explorating laparotomy was performed with an attempted intraperitoneal pelvic packing (A). Despite the intraperitoneal pelvic packing and then an external fixation, together with military antishock trousers, 3,000 mL of fluids, 2 fresh-frozen plasma units, and 20 packed RBC units, he remained in shock with 40 mm Hg SBP and suffered 3 cardiac arrests. An interventional radiologist, transferred urgently from the trauma center, performed the IABO in the operating room. The patient was transported by helicopter to the trauma center, directly to the angiographic room. A cardiac arrest occurred before embolization. The following are arteriographic findings: (A) note the external fixator and the swabs of the intraperitoneal packing; (B) major contrast extravasations from multiple wounds of the right external and internal iliac arteries and vasospasm of the left external iliac artery; (C) extravasations from branches of the right external iliac artery after gelfoam embolization of the right internal femoral artery; (D) persistence of bleeding sites from the common, deep, and superficial femoral arteries after initial gelfoam selective embolization of the right epigastric artery; and (E) embolization of both internal iliac arteries and the right external iliac artery with fragments of gelfoam, with the agreement of the vascular surgeon, because of the presence of multiple bleeding sites and the severe clinical status. Surgical thrombectomy of the external right iliac artery was performed immediately after the embolization. The patient survived without any sequelae. 11) or after embolization (n ϭ 1). Six cases had recrudescence of hemodynamic shock after balloon deflation. Two of these led to death (patients 5 and 13) despite immediate reinflation of the balloon. In another case (patient 9, Fig. 1) , reinflation of the balloon was temporarily required to treat the hemodynamic shock. For the three other patients, the shock was treated by resuscitation techniques only.
TAE Procedure
Twelve patients benefitted from angiography that revealed bilateral (n ϭ 8) or unilateral (n ϭ 3) bleeding sites and no bleeding site (n ϭ 1). Nine patients were embolized. TAE concerned the trunk of the internal iliac artery because of multiple bleeding sites from multiple branches (n ϭ 13), the iliolumbar artery (n ϭ 2), the sacral arteries (n ϭ 3), the superior gluteal artery (n ϭ 2), and the internal pudendal artery (n ϭ 1).
Outcome
The global mortality rate was 54% (7 of 13), and all deaths occurred during the first 24 hours, with a mean time to death of 6.6 hours Ϯ 4.5 hours. The first five patients died, whereas only two among the subsequent eight.
One patient died in the ICU despite IABO (patient 3). Two patients died in the angiographic room before embolization because of shock induced by the deflation of the balloon (patients 5 and 13). Two patients died in the angiographic room during embolization, because the hemorrhagic shock was worsened by a secondary hemoptysis (patient 1) or the recurrence of a hemothorax (patient 2). Two patients died in the ICU after embolization: one because of a coagulopathy and other of unknown cause (patients 12 and 4, respectively).
There were no statistically significant differences in presenting age, SBP, heart rate, pH, time before occlusion, or transfusion requirement between those who lived and those who died; the only significant difference between the two groups was mean ISS (p ϭ 0.011) and occlusion time (p ϭ 0.026; Table 4 ).
The two patients who presented with cardiac arrest before IABO survived. Six patients did not require any complementary intervention after embolization. Apart from orthopedic surgery, the embolization was immediately followed in one case by a hemostatic splenectomy and the surgical repair of a diaphragmatic hernia (patient 7) and, in two cases, by a femoral thrombectomy (patients 9 and 10). Patient 10 was at high risk of thrombosis because of major vasospasm and, in fact, developed a thrombosis of the left common femoral artery at the puncture point. The patient 9 ( Fig. 1) was first managed in a secondary hospital and then brought back to our center after an IABO was performed in the shock room. Deliberate embolization of the femoral artery controlateral to the femoral access site was agreed on with the vascular surgeon, before surgical hemostasis of the two groins, because there were multiple and bilateral bleeding sites that could not be treated by selective embolization.
DISCUSSION
Improvements in management, especially regarding resuscitation, pelvic stabilization, and embolization techniques, have contributed to decrease the mortality because of PF. Because hemorrhage is more often venous or bony in origin, the increase of pelvic pressure by hematoma and pelvic fixation is generally sufficient to ensure hemostasis. However, bleeding that leads to CUHS is usually arterial in origin and needs to be treated by embolization. 10, 12 Rarely, some patients are so critical that embolization cannot be proposed, because they are not transportable, and thus these patients are without any therapeutic recourse.
There is little information in the literature concerning this subgroup of patients in CUHS. The global mortality of PFs has been reported to be between 3% and 40%. [1] [2] [3] [4] In case of UHS, data are heterogeneous with mortality rates from 57% in case of shock 23 to 66% when the ISS is Ͼ50 and 100% when the ISS is Ͼ57. 8 No study has described a population of hemorrhagic shock because of PF as critical as ours, certainly because this situation is rare, Ͻ2% of PFs. 24, 25 When analyzing the hemodynamic state (mean SBP 41 mm Hg) of our population, the mean transfusion volume (5.6 L), the mean ISS (48), and the occurrence of cardiac arrests in two patients, it clearly seems that our population constituted patients who could be considered "almost dead." For example, six patients presented an ISS Ͼ57 and had, according to Vanveen et al., 8 a predicted mortality of 100%; thanks to IABO as one of them survived. According to David et al., 7 the two patients who presented cardiac arrests out of hospital and who survived had only 10% survival chance. The mortality rate in this series is rather high (54%), but conversely, one should consider that this technique has permitted the saving half of these patients.
As regards the interest of IABO, we should also refer to the effect on physiologic parameters. The mean increase of SBP after IABO was marked (70 mm Hg, p ϭ 0.001), allowing the control of hemorrhagic shock and transfer of patients to the embolization room. By this means, IABO may help to prevent fatal outcomes and seems to be of interest in the management of CUHS. Planning a protocol for the management of PF has been proven to be effective in decreasing mortality, in particular, by reducing delays. 24, 26 For patients with hemorrhagic shock after PF, it is our policy that the whole trauma team must be on site (ICU physician, surgeon, and radiologist) at the patient's arrival and the decision for IABO should be made as soon as possible when the patient becomes critically unstable. In our population, the mean time from admission to IABO appears to be rather high (110 minutes) and should be reduced. However, time from admission to IABO is not significantly increased in the nonsurvivor group. This may be explained by the fact that some patients who are hemodynamically stable at their arrival may worsen secondarily. Furthermore, after IABO, the patient must be transferred to the angiographic suite and embolized as quickly as possible. In our study, this point is demonstrated by the mean occlusion time being correlated with survival rate (p ϭ 0.026) rate. This implies the necessity to avoid any event that could increase the delay before embolization, such as further radiologic examination, even if the patient's hemodynamic status improves considerably after IABO. The correlation between time of occlusion and death may be explained by the consequences of legs ischemia that releases toxins after balloon deflation and may worsen hemodynamic shock and acidosis.
Another situation in which our procedure could have a place is management of patients admitted in secondary trauma centers without angiographic suite or interventional radiologist. The occlusion may help to stabilize the patient and allow transfer to a Level I trauma center. Indeed, in our study, a senior radiologist was transferred to a secondary hospital in two cases, with the aim of performing the IABO procedure and returning with the patient to the primary center.
The "blind" characteristic of the procedure allows performance of this technique in any medical unit, without the need for fluoroscopic guidance. This gives the possibility of using IABO in a secondary hospital without angiographic room, as we performed twice. Puncture and catheterization of a femoral artery in a patient with a bulky pelvic hematoma and a low SBP may be difficult, but we succeeded on all occasions.
This procedure is reliable as demonstrated by our technical success rate (100%). However, our two cases of primitive iliac occlusion illustrate the importance of ascertaining the lack of femoral pulses after balloon inflation. This was not systematically performed before these two patients.
Another point that should be stressed is the risk for reappearance of shock on balloon deflation. The procedure should be performed in close cooperation with the resuscitation team and hemodynamic tolerance to balloon deflation carefully tested. Alternatively, the embolization can be performed with the balloon still inflated, as was the case for patient 12 .
In comparing IABO with other techniques of salvage in PF, such as pelvic packing, the former is a minimally invasive treatment. It does not require any incision, and the balloon is retrieved after embolization. No foreign body is left intra-or extraperitoneally, as it occurs after pelvic packing, limiting concern for septic complications. In addition, the procedure avoids the complications of laparotomy incisions, including scarring and ventral hernias, and wound closure difficulties in obese patients. Furthermore, IABO can be used in combination with other management options such as pelvic binding or surgical procedures such as c-clamp or pelvic packing. 27, 28 This study suffers from several problems of bias. The main bias is that the technique has evolved over time. The fact that the first five patients died compared with only two among the next eight suggests a learning curve with the procedure. Indeed, we learned that we had to manage patients after IABO as quickly as possible and that we had to be cautious during balloon deflation. Another issue is the retrospective aspect of this study, because some data were missing or could not be evaluated, i.e., timing regarding transfusion (especially of RBC units) and drugs perfusion rates. Finally, the small patient population limited statistical evaluation for important criteria such as comparison between subgroups of survivors and nonsurvivors. A larger study is needed to clarify the place of the IABO in the management of PF.
CONCLUSION
Our study suggests that our innovative minimally invasive IABO procedure may be safe and effective to decrease the mortality rate in critical CUHS after PF. Nevertheless, the effect on mortality, the clinical efficiency, and the place of IABO in the management of CUHS after PF remains to be proven by further investigations.
